Literature DB >> 23636793

The uveitis and its relationship with disease activity and quality of life in Moroccan children with juvenile idiopathic arthritis.

M Ezzahri1, B Amine, S Rostom, Y Rifay, D Badri, N Mawani, S Gueddari, S Shyen, M Wabi, F Moussa, R Abouqal, B Chkirate, N Hajjaj-Hassouni.   

Abstract

The aim of our study is to investigate ocular involvement in juvenile idiopathic arthritis (JIA) and its relationship with disease activity and quality of life in Moroccan patients who suffer from JIA. This is a cross-sectional study conducted between January and June 2012 which includes patients with juvenile idiopathic arthritis (n = 30). All patients have undergone clinical and paraclinical assessment of JIA and a complete eye examination. Functional impairment is assessed by the Childhood Health Assessment Questionnaire while visual function is studied by the Effect of Youngsters' Eyesight in Quality of Life instrument (EYE-Q). Quality of life is assessed using the Pediatric Quality of Life Inventory Version 4.0 (PedsQL 4.0). Four patients (13.33 %) have uveitis with a confidence interval between 3.4 and 30.7. Involvement is bilateral in three children (75 %). One patient (25 %) has elevated intraocular pressure with loss of the right eye due to glaucoma. There is a strong but not significant relationship between uveitis and the number of awakenings (r = 0.71, p = 0.69) and morning stiffness (r = 3.05, p = 0, 21). This relationship is moderate with erythrocyte sedimentation rate (r = 0.48, p = 0.78) and C-reactive protein (r = 0.25, p = 0.88). A strong but not significant association is found between the overall quality of life assessed by the PedsQL 4.0 and visual function assessed by EYE-Q in the uveitis group (r = -0.64, p = 0.55). This study suggests that uveitis associated with JIA can present serious complications and could have a direct relationship with the activity of the JIA as well as with the quality of life of the patient.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23636793     DOI: 10.1007/s10067-013-2262-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  19 in total

1.  Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study.

Authors:  K Kotaniemi; H Kautiainen; A Karma; K Aho
Journal:  Ophthalmology       Date:  2001-11       Impact factor: 12.079

Review 2.  Prevention and management of cataracts in children with juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila Angeles-Han; Steven Yeh
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

3.  The importance of visual function in the quality of life of children with uveitis.

Authors:  Sheila T Angeles-Han; Kenneth W Griffin; Thomas J A Lehman; John R Rutledge; Stephen Lyman; Joseph T Nguyen; Melanie J Harrison
Journal:  J AAPOS       Date:  2010-03-17       Impact factor: 1.220

4.  Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.

Authors:  R K Saurenmann; A V Levin; B M Feldman; J B Rose; R M Laxer; R Schneider; E D Silverman
Journal:  Arthritis Rheum       Date:  2007-02

5.  Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients.

Authors:  K Kotaniemi; M Arkela-Kautiainen; J Haapasaari; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

6.  Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis.

Authors:  C S Foster; K Havrlikova; S Baltatzis; W G Christen; J Merayo-Lloves
Journal:  Acta Ophthalmol Scand       Date:  2000-10

7.  Prognosis of juvenile rheumatoid arthritis-associated uveitis.

Authors:  M P Paroli; S Speranza; M Marino; M P Pirraglia; P Pivetti-Pezzi
Journal:  Eur J Ophthalmol       Date:  2003 Aug-Sep       Impact factor: 2.597

8.  Course, complications, and outcome of juvenile arthritis-related uveitis.

Authors:  Kourosh Sabri; Rotraud K Saurenmann; Earl D Silverman; Alex V Levin
Journal:  J AAPOS       Date:  2008-09-12       Impact factor: 1.220

9.  Decreasing severity of chronic uveitis in children with pauciarticular arthritis.

Authors:  D D Sherry; E D Mellins; R J Wedgwood
Journal:  Am J Dis Child       Date:  1991-09

10.  Screening for uveitis in juvenile rheumatoid arthritis.

Authors:  M I Boone; T L Moore; O A Cruz
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1998 Jan-Feb       Impact factor: 1.402

View more
  3 in total

1.  Comprehensive Assessment of Quality of Life, Functioning, and Mental Health in Children With Juvenile Idiopathic Arthritis and Noninfectious Uveitis.

Authors:  Joseph McDonald; Amy Cassedy; Mekibib Altaye; Jennifer Andringa; Ashley M Cooper; Carolyn Drews-Botsch; George Engelhard; Theresa Hennard; Gary N Holland; Kirsten Jenkins; Scott R Lambert; Jessi Lipscomb; Courtney McCracken; Deborah K McCurdy; Najima Mwase; Sampath Prahalad; Jessica Shantha; Erin Stahl; Virginia Miraldi Utz; A Adrienne Walker; Steven Yeh; Sheila T Angeles-Han
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-06-08       Impact factor: 5.178

2.  Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.

Authors:  Tamas Constantin; Ivan Foeldvari; Jordi Anton; Joke de Boer; Severine Czitrom-Guillaume; Clive Edelsten; Raz Gepstein; Arnd Heiligenhaus; Clarissa A Pilkington; Gabriele Simonini; Yosef Uziel; Sebastian J Vastert; Nico M Wulffraat; Anne-Mieke Haasnoot; Karoline Walscheid; Annamária Pálinkás; Reshma Pattani; Zoltán Györgyi; Richárd Kozma; Victor Boom; Andrea Ponyi; Angelo Ravelli; Athimalaipet V Ramanan
Journal:  Ann Rheum Dis       Date:  2018-03-28       Impact factor: 19.103

3.  Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.

Authors:  Christoph Tappeiner; Sandra Schenck; Martina Niewerth; Arnd Heiligenhaus; Kirsten Minden; Jens Klotsche
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-01       Impact factor: 4.794

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.